Novel microsurgical management of uveitis-glaucoma-hyphema syndrome.

Int Ophthalmol

Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Mickevičiaus g. 9, 44307, Kaunas, Lithuania.

Published: July 2019

AI Article Synopsis

  • The study reports cases of uveitis-glaucoma-hyphema (UGH) syndrome in patients who had a single-piece acrylic intraocular lens (IOL) placed in the capsular bag, highlighting its connection to IOL instability.
  • Three patients with UGH syndrome underwent microsurgical IOL fixation to the iris after experiencing complications from weak zonules, and their condition was monitored for visual acuity, intraocular pressure, and medication use before and 6 months post-surgery.
  • Results showed that the IOL fixation procedure effectively stabilized the lenses without causing further issues, leading to improvement in symptoms and preventing recurrence of UGH syndrome.

Article Abstract

Purpose: To report a series of cases and microsurgical management of rarely occurring uveitis-glaucoma-hyphema (UGH) syndrome in patients with single-piece acrylic intraocular lens (IOL) placed in the capsular bag.

Methods: It was a series of patients with UGH syndrome induced by posterior chamber IOL/capsular bag complex instability (pseudophakodonesis), who underwent IOL fixation to the iris. Visual acuity, intraocular pressure, number of glaucoma medications and IOL status (position) were recorded by the same protocol before and 6 months after the surgical treatment.

Results: The case series presents three patients with UGH syndrome caused by single-piece acrylic IOL placed in-the-bag. Each patient had uneventful phacoemulsification with posterior chamber IOL implantation few years ago and pseudophakodonesis caused by weakened zonules from pseudoexfoliation with subsequent development of UGH syndrome. IOL fixation to the iris with satisfactory postoperative results was performed due to the development of UGH. Signs of syndrome did not recur 6 months after the operation.

Conclusion: UGH syndrome can be induced by unstable in-the-bag IOL due to zonular laxity. Depending on the severity of the syndrome, this condition can be fought by applying a minimally invasive approach-IOL suturing to the iris with direct observation under the surgical microscope precisely in the anticipated location with no or minimal pupil deformation. Symptoms of UGH did not recur due to increased stability of the IOL and, as a result of this, declined irritation of the uveal tissue.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10792-018-0972-5DOI Listing

Publication Analysis

Top Keywords

ugh syndrome
20
microsurgical management
8
syndrome
8
single-piece acrylic
8
iol
8
patients ugh
8
syndrome induced
8
posterior chamber
8
iol fixation
8
fixation iris
8

Similar Publications

Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report.

World J Clin Cases

October 2024

Glaucoma and Cataract, Department of Ophthalmology, King Abdulaziz University Hospital, King Saud University, Riyadh 15112, Saudi Arabia.

Article Synopsis
  • * A case was reported involving a 55-year-old woman who developed hyphema and pigmentation after AGV implantation, leading to the rare UGH syndrome, which was not previously documented as a complication of this surgery.
  • * Following a second surgery to adjust the AGV tube, the patient's IOP improved, and she showed no further signs of complications, highlighting the importance of regular follow-up for patients after AGV implantation.
View Article and Find Full Text PDF

A case of delayed recurrent hyphema following Implantable Collamer Lens (ICL) surgery.

Am J Ophthalmol Case Rep

December 2024

The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Prevention and Treatment on Major Blinding Diseases, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, 400016, PR China.

Purpose: To present a case of delayed recurrent hyphema following toric ICL implantation.

Observations: This case reports a 24-year-old Asian female who presented with sudden decrease in vision in the right eye, accompanied by recurrent massive anterior chamber hemorrhage, six months after bilateral implantation of toric ICL with central holes for myopia correction. Despite initial conservative treatment with immobilization and intraocular pressure (IOP)-lowering medication at another hospital, the hyphema persisted.

View Article and Find Full Text PDF

Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation.

View Article and Find Full Text PDF

Uveitis-glaucoma-hyphema (UGH) syndrome is a rare condition characterized by intraocular inflammation, elevated intraocular pressure, and recurrent hyphema. Although UGH syndrome is typically caused by chafing between an intraocular lens and the iris or ciliary body, microinvasive glaucoma devices are becoming increasingly recognized as potential causes of recurrent intraocular inflammation. Herein, we discuss a case of UGH syndrome due to the subtle malposition of a Hydrus microstent that ultimately required surgical removal to manage.

View Article and Find Full Text PDF

To report the first case of uveitis-glaucoma-hyphema (UGH) syndrome post implantable collamer lens (ICL). Case report A 41-year-old female presented to our clinic complaining of bilateral eye pain and redness for two weeks. Her past medical history was significant for ICL, in both eyes and multiple sclerosis controlled with treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!